TET2 and acute myeloid leukemia: The mechanism by which the TET2 loss‐of‐function mutations induce clonal expansion remains in question and likely holds the answer to an apparent paradox: despite the clear association between TET2 mutations and hyperproliferative states, TET2 mutations are not always identified as the driving or founding mutation in AML.